SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-022339
Filing Date
2022-11-07
Accepted
2022-11-07 08:12:25
Documents
14
Period of Report
2022-11-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cinc-20221103.htm   iXBRL 8-K 70313
2 EX-99.1 cinc-ex99_1.htm EX-99.1 23365
3 GRAPHIC img73281002_0.jpg GRAPHIC 5241
  Complete submission text file 0000950170-22-022339.txt   229905

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cinc-20221103.xsd EX-101.SCH 2451
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cinc-20221103_lab.xml EX-101.LAB 13904
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cinc-20221103_pre.xml EX-101.PRE 10218
8 EXTRACTED XBRL INSTANCE DOCUMENT cinc-20221103_htm.xml XML 4879
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41201 | Film No.: 221363811
SIC: 2834 Pharmaceutical Preparations